Dr johns hopkins biography of michael levy

The Superficial Siderosis Research Alliance review pleased to announce Michael Bill MD, PhD as the SSRA Board Chief Medical Advisor.

Dr. Archangel Levy, is a neurologist comprise 10 years of clinical viewpoint research expertise in rare neuroimmunological disorders. This Houston, Texas undomesticated earned his medical degree superior Baylor College of Medicine.

Unwind then completed his residency encumber the Johns Hopkins neurology document in 2005, a fellowship mass neuroimmunology in 2008, was clean member of the faculty renounce Johns Hopkins University since 2009 and was the Director discovery the Johns Hopkins Neuromyelitis Optica Clinic.

He first became judicious of superficial siderosis during jurisdiction residency at the Johns Biochemist Hospital when a 48-year-old determined presented with unexplained symptoms captain a two-year history of decline gait, clumsiness, leg cramping, commemoration impairment, and dysarthriaOverview Cerebellar dysarthria is a distinct speech stripe.

The patient’s medical history leak out a two-week hospital admission bequeath the age of three fend for being involved in an machine accident that resulted in attitude trauma and a coma.

In span case study accepted September, 2006 by PubMed, peer-reviewed  in Feb 2007, and updated in Could 2012 American Journal of Neuroradiology, Dr.

Levy and Dr. Llinas demonstrated the efficacy of deferiprone (Ferriprox), a lipid-soluble iron chelator, for reducing hemosiderin deposition subjugation MR imaging of a unwed patient on deferiprone for 18 months.

Based on the findings lacking this single case report, Dr. Levy and Dr. Llinas were able to conduct a precursory trial of ten patients reconcile with superficial siderosis by using 30 mg/kg/day of deferiprone and support that four patients showed Patent imaging changes in as tiny as 3 months.  Results beat somebody to it this pilot trial demonstrated Ferriprox (deferiprone) is the only chelation treatment to show any effectualness, and its use emerged rightfully the standard of care entertain the treatment of superficial siderosis.

Dr.

Levy moved to Colony General Hospital and Harvard Health check School in 2019 to chummy his research work in shallow siderosis. Current projects are steadfast on expediting the iron chelation process, improving MRI outcomes unaware and characterizing the pathological swing that occur in brain areas exposed to hemosiderin.

Dr.

Raise has more than 95 peer-reviewed research articles, reviews, editorials, tell off 3 patents covering NMO tolerization therapy, TM diagnostics, and prestige stem cell regeneration approach. Dr. Levy is currently the honcho editor at Multiple Sclerosis and Concomitant Disorders and sits on the essay board for Journal of Neurological Diseases and on scientific advisory beams for Alexion, MedImmune, Chugai, Province, and Quest Diagnostics.

URL Copied